+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "DNA Damage Response"

From
DNA Repair Drugs Global Market Report 2024 - Product Thumbnail Image

DNA Repair Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Global DNA Repair Drugs Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Global DNA Repair Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
DNA Repair Drugs: Global Markets - Product Thumbnail Image

DNA Repair Drugs: Global Markets

  • Report
  • February 2022
  • 112 Pages
  • Global
From
Human Recombinant DNA: Global Markets - Product Thumbnail Image

Human Recombinant DNA: Global Markets

  • Report
  • July 2022
  • 84 Pages
  • Global
From
From
Olaparib + bevacizumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Olaparib + bevacizumab Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
  • 17 Results (Page 1 of 1)
Loading Indicator

The DNA Damage Response (DDR) market is a subset of the genomics industry that focuses on the detection and repair of DNA damage. DDR is a complex process that involves the recognition of damaged DNA, the activation of repair pathways, and the restoration of the original DNA sequence. DDR is essential for maintaining genomic integrity and preventing the development of diseases such as cancer. DDR technologies are used in a variety of applications, including cancer diagnostics, drug discovery, and gene therapy. Companies in the DDR market are developing products and services that enable researchers to identify and repair DNA damage. These products include DNA repair enzymes, DNA damage detection kits, and DNA repair assays. Companies in the DDR market include Thermo Fisher Scientific, Illumina, Agilent Technologies, Merck KGaA, and Bio-Rad Laboratories. Show Less Read more